MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Second Quarter 2009 Financial and Operational Results
14 Julho 2009 - 9:13AM
Business Wire
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is scheduled to
announce its financial results for the 2009 second quarter on
Thursday, August 6, 2009, before the market opens. At 9:00 a.m.
(ET) on that day, MiddleBrook management will conduct a conference
call to review results for the 2009 second quarter.
To listen live to the call, dial 1-800-813-8504 or
1-660-422-4526. A replay of the call will be available starting at
approximately 11 a.m. on August 6 through 5 p.m. on August 13,
2009. To listen to the replay, dial 1-800-642-1687 or
1-706-645-9291, and enter the conference ID #19864871.
A live audio webcast of the conference call also will be
available by going to the Investor Relations section of
MiddleBrook's web site, www.middlebrookpharma.com. A replay of the
webcast will be available starting at approximately 11 a.m. on
August 7 through 5 p.m. on Sept. 4, 2009.
About MiddleBrook
Pharmaceuticals:
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a
pharmaceutical company focused on developing and commercializing
anti-infective products that fulfill unmet medical needs. The
Company has developed a proprietary delivery technology called
PULSYS�, which enables the pulsatile delivery, or delivery in rapid
bursts, of certain drugs. MiddleBrook is currently developing a
portfolio of anti-infective PULSYS products. The Company�s
near-term corporate strategy is to improve dosing regimens and/or
reduce frequency of dosing which it believes will result in
improved patient dosing convenience and compliance for antibiotics
that have been used and trusted by physicians and patients for
decades. MiddleBrook currently markets KEFLEX, the
immediate-release brand of cephalexin, and MOXATAG � the first and
only FDA-approved once-daily amoxicillin. For more information
about MiddleBrook, please visit www.middlebrookpharma.com.
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Middlebrook Pharmaceuticals (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de MiddleBrook Pharmaceuticals, Inc.